Detecting Chronic Kidney Disease Early
Official title: Cross-sectional Study on the Early Detection of Chronic Kidney Disease
Run by Consorci Sanitari de l'Alt Penedès i Garraf · NCT06950151 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study looks at how well doctors are sending patients to kidney specialists through teleconsultation to see if they are doing it at the right time and for the right reasons.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 385 (estimated) |
| Sponsor | Consorci Sanitari de l'Alt Penedès i Garraf Academic / other |
| Locations | 1 site (Sant Pere de Ribes, Barcelona) |
| Trial ID | NCT06950151 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 years old who have been referred to nephrology from primary care and meet specific referral criteria.
✕Probably not a fit
Patients with a prior diagnosis of chronic kidney disease or those who have undergone renal replacement therapy will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates how effectively patients are referred from primary care to a nephrology teleconsultation service in the Garraf region. It focuses on the timing of referrals and the appropriateness of these referrals based on established criteria. By analyzing patient data from January to December 2024, the study aims to identify gaps in the referral process for chronic kidney disease management.
Why it matters
Potential benefit: If successful, this study could improve early detection and management of chronic kidney disease, leading to better patient outcomes.
How similar studies have gone: While this approach is observational and may not have been extensively tested in this specific context, similar studies have shown the importance of timely referrals in managing chronic conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women over 18 years of age * Teleconsultation to nephrology from Primary Care in the Garraf region during the period from January to December 2024 * Patients with at least one referral criterion for the nephrology service Exclusion Criteria: Participants diagnosed with any of the following conditions: * Patients with Chronic Kidney Disease previously evaluated by the nephrology service. * History of requiring renal replacement therapy (hemodialysis, peritoneal dialysis, or kidney transplantation). * Patients hospitalized within the last 3 months with a diagnosis of kidney failure. * Patients with a known prior diagnosis of Autosomal Dominant Polycystic Kidney Disease or glomerular diseases.
Where it's running
-
Consorci Sanitari Alt Penedés-Garraf
Sant Pere de Ribes, Barcelona, Spain Recruiting
Study contacts
- Principal investigator: Ignacio Manzur, MD — Csapg
- Study coordinator: Ignacio Manzur, MD
- Email: rimanzur@csapg.cat
- Phone: 0034938960025
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Impact of TAVR on kidney function in people with aortic valve disease
This registry tests how trans-catheter aortic valve implantation affects kidney function and the risk of kidney injury in adults with aortic stenosis.
-
Calciphylaxis in people with chronic kidney disease: causes, risks, and early signs
This project will compare adults with chronic kidney disease who develop calciphylaxis to matched CKD patients who do not, collecting clinical data and biological samples to try to find risk factors and early signs.
-
Oral Semaglutide for CKD and MAFLD in adults with diabetes
This study tests whether adding oral semaglutide to standard care can slow kidney and liver disease progression in adults with CKD and MAFLD who have type 2 diabetes.
-
Eye-brain-kidney connections in chronic kidney disease
This study will see if changes in brain network connectivity and retinal blood vessels are linked to cognitive decline and kidney function in adults with chronic kidney disease.
-
Screening for chronic kidney disease
We will see how common chronic kidney disease is among adults followed at a tertiary care center and how many cases were previously undiagnosed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.